Saori Nishijima Selected Research

distigmine (distigmine bromide)

1/2014	[Effect of distigmine at 5 mg daily in patients with detrusor underactivity].
5/2012	Effect of distigmine combined with propiverine on bladder activity in rats with spinal cord injury.
1/2010	Demonstration of muscarinic and nicotinic receptor binding activities of distigmine to treat detrusor underactivity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Saori Nishijima Research Topics

Disease

9	Spinal Cord Injuries (Spinal Cord Injury) 01/2020 - 09/2003
8	Overactive Urinary Bladder (Overactive Bladder) 01/2021 - 12/2007
7	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2021 - 08/2002
6	Hyperemia 12/2019 - 01/2016
6	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 10/2019 - 10/2006
6	Body Weight (Weight, Body) 09/2011 - 03/2002
4	Lower Urinary Tract Symptoms 12/2019 - 10/2009
4	Nocturia 01/2018 - 01/2008
4	Interstitial Cystitis (Interstitial Cystitis, Chronic) 05/2017 - 12/2002
3	Neoplasms (Cancer) 01/2019 - 03/2002
3	Underactive Urinary Bladder 01/2014 - 10/2007
3	Hyperoxaluria (Oxaluria) 06/2006 - 02/2003
2	Urge Urinary Incontinence (Urge Incontinence) 04/2021 - 01/2016
2	Pain (Aches) 04/2021 - 11/2014
2	Constipation 01/2021 - 01/2018
2	Hypertrophy 01/2020 - 12/2009
2	Prostatitis 01/2016 - 11/2014
2	Abnormal Reflex (Hyperreflexia) 05/2013 - 12/2005
2	Urinary Incontinence 09/2010 - 03/2002
2	Edema (Dropsy) 01/2008 - 04/2007
2	Vitamin B 6 Deficiency (Pyridoxine Deficiency) 06/2006 - 02/2003
2	Cataract (Cataracts) 05/2005 - 03/2004
1	Hyperalgesia 01/2022
1	Urologic Diseases (Urinary Tract Disease) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Erythema 01/2018
1	Fatigue 01/2018
1	Urinary Retention 01/2018
1	Pelvic Pain 05/2017
1	Atrophy 01/2016
1	Nausea 11/2014
1	Exanthema (Rash) 11/2014
1	Stress Urinary Incontinence 10/2014
1	Fibrosis (Cirrhosis) 05/2013
1	Painful Neuropathy 11/2009
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2009
1	Hematuria 04/2009

Drug/Important Bio-Agent (IBA)

11	Glycine (Aminoacetic Acid)FDA LinkGeneric 04/2021 - 09/2003
7	naftopidilIBA 12/2019 - 08/2002
6	Glutamic Acid (Glutamate)FDA Link 12/2019 - 01/2005
6	propiverineIBA 01/2019 - 10/2006
5	salicylhydroxamic acid (SHAM)IBA 12/2019 - 10/2007
4	Cholinergic Agents (Cholinergics)IBA 01/2019 - 01/2010
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019 - 02/2007
3	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 02/2007
3	Adrenergic Receptors (Adrenergic Receptor)IBA 05/2016 - 12/2002
3	Pharmaceutical PreparationsIBA 11/2014 - 02/2008
3	CatecholaminesIBA 10/2014 - 04/2007
3	distigmine (distigmine bromide)IBA 01/2014 - 01/2010
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 10/2016
2	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2019
2	tranilastIBA 05/2017 - 11/2013
2	Serotonin (5 Hydroxytryptamine)IBA 05/2016 - 02/2007
2	Epinephrine (Adrenaline)FDA LinkGeneric 05/2016 - 02/2007
2	eviprostatIBA 01/2016 - 02/2008
2	Adenosine Triphosphate (ATP)IBA 10/2009 - 02/2008
2	Amino Acids FDA Link 02/2007 - 12/2006
2	Alanine-glyoxylate transaminase (alanine-glyoxylate aminotransferase)IBA 06/2006 - 02/2003
2	OxalatesIBA 05/2004 - 02/2003
2	AntigensIBA 03/2002 - 03/2002
1	Dinoprostone (PGE2)FDA Link 01/2022
1	HydrogenIBA 01/2021
1	Solifenacin Succinate FDA Link 01/2020
1	mirabegronIBA 01/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020
1	Taurine FDA Link 12/2019
1	gamma-Aminobutyric Acid (GABA)IBA 12/2019
1	BicucullineIBA 12/2019
1	StrychnineIBA 12/2019
1	Tadalafil (Cialis)FDA Link 01/2019
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	Muscarinic AntagonistsIBA 01/2018
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2018
1	8-Hydroxy-2'-DeoxyguanosineIBA 10/2016
1	Isoflurane FDA LinkGeneric 10/2016
1	silodosin FDA Link 10/2016
1	carbazochrome (Adona)IBA 11/2014
1	Cholinergic Antagonists (Anticholinergics)IBA 10/2014
1	imidafenacinIBA 09/2012
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 05/2012
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2010
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2010
1	Connexin 43 (Connexin43)IBA 12/2009
1	ConnexinsIBA 12/2009
1	Natriuretic PeptidesIBA 01/2008
1	MelatoninIBA 01/2008

Therapy/Procedure

6	Therapeutics 01/2018 - 03/2002
2	Oral Administration 12/2019 - 05/2013
2	Spinal Injections 05/2013 - 12/2005
2	Prostatectomy (Retropubic Prostatectomy) 04/2009 - 03/2002
2	Phacoemulsification 05/2005 - 03/2004
1	Ligation 10/2019
1	Anesthesia 01/2019
1	Castration 01/2016
1	Catheters 09/2011
1	Aftercare (After-Treatment) 09/2010
1	Glycemic Control 11/2009